Outset Medical (OM) Earnings Analysis
Outset Medical (OM) has no confirmed upcoming earnings date. Last quarter (2026-02-11) it missed with EPS -0.84 USD vs -0.67387 USD est (-24.7%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -0.99.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OM next report earnings?
No confirmed upcoming earnings date is currently scheduled for OM. This page updates as the calendar is published.
OM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-11 | -0.84 USD | -0.67387 USD | -24.7% | Miss |
| 2025-11-10 | -0.69 USD | -0.655 USD | -5.3% | Miss |
| 2025-02-19 | -5.55 USD | -6.20062 USD | +10.5% | Beat |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
OM valuation and analyst view
| Trailing P/E | -0.99 |
|---|---|
| Trailing EPS | -4.0738 USD |
| Price / book | 0.68 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
| Analyst consensus | Buy (7 buy / 3 hold / 1 sell) |
| Avg price target | 11 USD |
Related research pages
Frequently asked questions
When is Outset Medical (OM)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for OM. This page updates as the calendar is published.
Did OM beat earnings last quarter?
In its 2026-02-11 report, OM posted EPS of -0.84 USD versus a -0.67387 USD estimate — a miss of 24.7%.
What is OM's earnings track record?
Over the last 3 reported quarters with consensus data, OM beat estimates 1 times (33%).
What is OM's current P/E ratio and EPS?
OM trades at a trailing P/E of -0.99 on trailing EPS of -4.073803951450498 USD.
What do analysts rate OM?
Analyst consensus is "Buy" across 11 ratings (0 strong buy, 7 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 11 USD.